HSP90B2P and central nervous system cancer: Polylactic-co-glycolic acid (PLGA) nanoparticles were synthesized and loaded with Hsp to form hesperidin nanoparticles (HspNPs) to determine its potential application as an anticancer agent against C6 glioma cells.